Innovating Works

MEDICA SCIENTIA INNOVATION RESEARCH

Activa
I3LUNG: Integrative science, Intelligent data platform for Individualized LUNG cancer care with Immunotherap... FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-CARE-05-02 Immunotherapy (IO) is the new standard of care for many patients with advanced Non-Small Cell Lung Cancer (aNSCLC), yet only around 30-50% o...
2022-05-23 - 2027-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.